Up2B Accelerator’s Post

🚀 Great to work together with Up2B Accelerator! As an investor and with ff2-Consulting GmbH, I offer my financial and M&A expertise to startups and mid-cap companies #CFOaaS #StartupFinance #FinancialStrategy #Entrepreneurship #StartupSuccess #FinancialManagement #BusinessGrowth #ScaleSmart #FinanceExperts 

The venture capital industry functions in large part on the belief that great innovators capture the lion’s share of value from their breakthroughs. So, in re-making the world, how much value do disruptive entrepreneurs actually capture from their innovations? PLUS: Haystacks of Needles; Complexity and Philosophy; The Middle Path to Innovation; Ramsey Theory: order from chaos; and The Information Theory of Aging

🃏 𝗣𝗶𝘁𝗰𝗵 𝗗𝗲𝗰𝗸𝘀 𝗔𝗿𝗲 𝗚𝗿𝗲𝗮𝘁—𝗕𝘂𝘁 𝗛𝗮𝘃𝗲 𝗬𝗼𝘂 𝗧𝗿𝗶𝗲𝗱 𝗮𝗻 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗠𝗲𝗺𝗼? 🚀 𝘌𝘷𝘦𝘳 𝘸𝘰𝘯𝘥𝘦𝘳𝘦𝘥 𝘸𝘩𝘺 𝘴𝘰𝘮𝘦 𝘴𝘵𝘢𝘳𝘵𝘶𝘱𝘴 𝘴𝘦𝘤𝘶𝘳𝘦 𝘧𝘶𝘯𝘥𝘪𝘯𝘨 𝘦𝘧𝘧𝘰𝘳𝘵𝘭𝘦𝘴𝘴𝘭𝘺 𝘸𝘩𝘪𝘭𝘦 𝘰𝘵𝘩𝘦𝘳𝘴 𝘴𝘵𝘳𝘶𝘨𝘨𝘭𝘦? 𝘊𝘰𝘶𝘭𝘥 𝘵𝘩𝘦 𝘴𝘦𝘤𝘳𝘦𝘵 𝘭𝘪𝘦 𝘪𝘯 𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘢𝘴 𝘴𝘪𝘮𝘱𝘭𝘦 𝘢𝘴 𝘢𝘯 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘮𝘦𝘮𝘰? At the Innovation Office University of Basel , our committment is to empower startups to navigate the complex landscape of funding - see our recent activities in bringing investors and startups together! Here, one key tool that often goes overlooked is the 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗺𝗲𝗺𝗼. Rarely taught in startup ecosystems, this simple document can be incredibly useful, especially in deep tech, biotech, or life sciences. Let’s find out why founders should embrace this tool early on! 📄 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗮𝗻 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗠𝗲𝗺𝗼? An investment memo is a clear and concise document that outlines the why investing in your company is a great idea. It covers everything from your mission, market opportunity, and traction, to how you'll use the funds raised. Unlike a pitch deck, which often relies on visuals, the memo stands on its own. It can serve as your voice when you’re not in the room—paving the way for a meaningful conversation with potential investors. The 𝗬 𝗖𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗼𝗿 𝘁𝗲𝗺𝗽𝗹𝗮𝘁𝗲 below emphasizes clarity: ♦️ What problem do you solve, and why does it matter? ♦️ How does your solution change the current landscape? ♦️ What metrics prove your traction? ♦️ Who is your target market, and how do you plan to capture it? E.g., a biotech startup focusing on personalized medicine could use the memo to clearly articulate the scale of its market (e.g., the $100B+ precision medicine sector), its unique IP, and early clinical results. This sets the narrative before investors dive into financials. 📊 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗜𝗺𝗽𝗮𝗰𝘁 Investment memos aren’t just theoretical. Startups like Rippling used one to successfully close their Series A round by ensuring every investor was aligned with their vision before the meeting even started. For biotech founders, explaining regulatory hurdles, clinical validation, or scalability in a memo can prevent misunderstandings and build trust early on. 🔍 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀 𝘁𝗼 𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 Many founders focus solely on pitch decks, but an investment memo forces you to clarify your vision, strategy, and market fit. It's not just a tool for VCs; it is a strategic tool for you to deeply understand and articulate your business. 🔗 Found this useful? Please like, comment, and reshare to help others in your network! Stay tuned for more startup world insights, every Sun. 8h30 CET. #StartupStrategy #FundraisingTips #InnovationEcosystem #BiotechStartups #DeepTech

𝗔𝗿𝗲 𝗩𝗖𝘀 𝗮𝗻𝗱 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗱𝗶𝘃𝗶𝗻𝗴 𝗵𝗲𝗮𝗱𝗳𝗶𝗿𝘀𝘁 𝗶𝗻𝘁𝗼 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀? 𝗡𝗼𝘁 𝘀𝗼 𝗳𝗮𝘀𝘁! In the world of startup investing, due diligence is non-negotiable. However, there's a key aspect many overlook - Regulatory Approval. Yes, as shocking as it is! Upon investing in MedTech, it's easy to get carried away with exciting marketing strategies and the potential for high returns. But here's the catch - without regulatory approval, you can't legally sell. Imagine pouring thousands into marketing, only to find that the product can't legally hit the market. That would be a waste, wouldn't it? Early regulatory due diligence isn't just about avoiding pitfalls. It's also about crafting a strategic roadmap. Knowing which markets to tackle first, what hurdles to anticipate and how to navigate them - that's the real game changer. Invest smart. Make regulatory due diligence your priority. It's not just about protecting your investment. It's about setting the stage for a successful enterprise. Don't just dive in. Do your homework. Make sure you're investing in a startup that's not just promising, but also prepared to navigate the complex regulatory landscape and will have the resources to do so. Remember, the most successful investors are not those who dive in without looking, but those who take the time to understand the water's depth. So, before you make your next MedTech investment, ask yourself, '𝗛𝗮𝘃𝗲 𝗜 𝗱𝗼𝗻𝗲 𝗺𝘆 𝗱𝘂𝗲 𝗱𝗶𝗹𝗶𝗴𝗲𝗻𝗰𝗲?' #MedTech #VC #Investors #MedicalDevices #DueDilligence

Dive into the latest global market trends in venture-backed businesses with in-depth analysis from @daxgrant 🌍 Discover how evolving dynamics are shaping the future of startups and investment landscapes worldwide. From shifting consumer behaviours to emerging technologies, our article covers the key trends that every entrepreneur and investor needs to know to stay ahead of the curve. 🔔Subscribe to the UK's leading business news platform here: https://lnkd.in/eDbcQvmg 📚Read the full article here: https://lnkd.in/e33MJcnc #VentureCapital #GlobalMarketTrends #Startups #Investment #BusinessGrowth #Entrepreneurship

DealRoom’s recent report highlights the remarkable value of the University of Cambridge’s tech ecosystem. The UK leads Europe in deriving value from universities through patents, venture capital funding, unicorns, and overall valuation. Cambridge ranks third globally in deep tech output, following Boston, despite being a city of just 150,000 people. This small yet powerful ecosystem contributes 18% of the UK’s overall tech ecosystem value with only 3% of the funding, producing $16.9 in value for every $1 of venture capital investment. Additionally, the University of Oxford ranks in fifth place, meaning the UK has two innovation hotspots for producing ground-breaking technologies. This underscores the huge potential when academia, entrepreneurship, and venture capital converge. Read the full report here: https://lnkd.in/eMen3-ck #cambridgeuniversity #deeptech #techinnovation #techleadership #venturecapital #vc

Although Govo is not geographically limited in our investment focus, we pay close attention to venture capital trends in our home state of Florida. eMerge Americas recently released its 2023 Annual Insights Report, which offered a valuable look at Florida’s venture capital landscape. Notably:   Despite 2023 being a significant down year, Florida-based companies still received nearly $3.5 billion in investment across 673 deals. Highlights include investment in fintech, healthtech, and AI innovation, with a healthy rise in investments in climatetech/cleantech. The largest funding round in a Florida company in 2023 was in edtech. Each of these categories overlap closely with Govo’s focus on investing in companies for which doing business with government or navigating government regulations is an important success factor. We look forward to learning more about rising companies in each of these sectors. Rob Panepinto Jonathan Kilman 1858 Capital Partners  

𝗔𝗿𝗲 𝗩𝗖𝘀 𝗮𝗻𝗱 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗱𝗶𝘃𝗶𝗻𝗴 𝗵𝗲𝗮𝗱𝗳𝗶𝗿𝘀𝘁 𝗶𝗻𝘁𝗼 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀? 𝗡𝗼𝘁 𝘀𝗼 𝗳𝗮𝘀𝘁! In the world of startup investing, due diligence is non-negotiable. However, there's a key aspect many overlook - Regulatory Approval. Yes, as shocking as it is! Upon investing in MedTech, it's easy to get carried away with exciting marketing strategies and the potential for high returns. But here's the catch - without regulatory approval, you can't legally sell. Imagine pouring thousands into marketing, only to find that the product can't legally hit the market. That would be a waste, wouldn't it? Early regulatory due diligence isn't just about avoiding pitfalls. It's also about crafting a strategic roadmap. Knowing which markets to tackle first, what hurdles to anticipate and how to navigate them - that's the real game changer. Invest smart. Make regulatory due diligence your priority. It's not just about protecting your investment. It's about setting the stage for a successful enterprise. Don't just dive in. Do your homework. Make sure you're investing in a startup that's not just promising, but also prepared to navigate the complex regulatory landscape and will have the resources to do so. Remember, the most successful investors are not those who dive in without looking, but those who take the time to understand the water's depth. So, before you make your next MedTech investment, ask yourself, '𝗛𝗮𝘃𝗲 𝗜 𝗱𝗼𝗻𝗲 𝗺𝘆 𝗱𝘂𝗲 𝗱𝗶𝗹𝗶𝗴𝗲𝗻𝗰𝗲?' #MedTech #VC #Investors #MedicalDevices #DueDilligence

Calling all European startups: apply to have the opportunity to pitch your solution at the European Angel Investment Summit! 🗓 15-16 October | Brussels The largest gathering of angel investors in Europe will be taking place, organized by EBAN - European Business Angel Network, the leading pan-European early-stage investor network. For this year's event, selected early-stage European startups who are seeking funding opportunities will have the chance to pitch their innovative projects to investors and key industry players. There is 1 week left to apply... learn more and submit your application before September 15th: https://bit.ly/3z8Wi1E This year, the European Commission's Directorate-General for Defence Industry and Space (DG DEFIS) is partnering with the European Business Angel Network to organize the Defence Tech Investor Forum, which will take place on October 15th. The Forum will highlight in-depth conversations between startups, the defense industry, investors, and EU and government representatives. Kadi Silde, our global Chief Development Officer, will take part in a panel discussion on the opportunities and challenges of investing in defense technologies, and strategies to stimulate investment in innovative defense technologies. cc: Starburst Ventures, François Chopard #EBAN #EU #event #euspace #spacetech #startup #matchingmaking #founder #entrepreneur